AHA2020: No Benefit for Omega-3 in STRENGTH Trial
A daily dose of a novel omega-3 carboxylic acid (EPA+DHA) compound did not reduce the risk of heart attacks, stroke, revascularization (stenting or bypass surgery), hospitalization for unstable angina, or cardiovascular (CV)...
Read More